A curated collection of articles, insights, and strategy patterns related to Glp1 Market.
A forensic analysis bridging Novo Nordisk's 2023 market capture to the 2026 GLP-1 reality: Eli Lilly's duopoly incursion, $11B fill-finish capex, and next-gen pipeline threats.
ONLINE